Hutch News
Results per Page:
New Science Spotlight Articles
Every month, Fred Hutch postdoc writer/editors summarize two papers from each of our scientific divisions to stimulate collaborations across campus
May 24, 2023
Diffuse large B cell lymphoma gets new first line therapy
From the Gopal laboratory, Clinical Research Division, and the Smith laboratory, University of Washington Medical Oncology
Scientists learn how common virus reactivates after transplantation
New Science paper describes how antibody-producing B cells, not disease-fighting T cells, protect against reactivation of cytomegalovirus
Colette Chaney named ‘2018 Nurse of the Year for Research Advancement’
March of Dimes Washington honors the longtime immunotherapy clinical research nurse
Hutch science featured at world's premier cancer immunotherapy meeting
Researchers honored at SITC 2018 for work on immune-based treatments for leukemia, ovarian cancer, skin cancer
Cancer cells evade immunotherapy by hiding telltale marker, suggesting how to stop relapse
A Nature Communications report explains why some Merkel cell carcinoma patients treated with immunotherapy see their cancers shrink at first but then come back.
First in-depth profile of CAR T-cell signals suggests how to improve immunotherapy
A Science Signaling paper reports how two common CAR designs impact T-cell efficacy against cancer in the laboratory
3 new projects map out immune responses to cancers
Scientists aim to gather knowledge that improves future immunotherapies
CAR T cells manufacture upgrades
From the Till lab, Clinical Research Division
6 things to know about glioblastoma
Following Sen. John McCain’s diagnosis, Fred Hutch experts offer ‘the long view’ on brain cancer research